Average Co-Inventor Count = 4.69
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (9 from 3,684 patents)
2. Bristol-myers Company (1 from 637 patents)
3. Bristol-myers (1 from 6 patents)
11 patents:
1. 8338606 - Crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N-((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamide
2. 8252821 - Bioavailable capsule compositions of amorphous alpha-(N-sulfonamido)acetamide compound
3. 8202996 - Crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N- ((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamide
4. 6455575 - Phosphonooxymethyl ethers of taxane derivatives
5. 6207650 - Antiviral, highly water soluble, stable, crystalline salts of 2′, 3′-dideoxyinosine, 2′, 3′-dideoxy-2′, 3′-didehydrothymidine and 2′, 3′-dideoxy-2′-fluoroinosine
6. 5646176 - Phosphonooxymethyl ethers of taxane derivatives
7. 5608048 - d.sub.4 T polymorphic Form 1 process
8. 5455270 - Stabilized solutions of platinum(II) antitumor agents
9. 5196555 - Water and solvent soluble axial hydroxy and mono- and di- carboxylic
10. 4946689 - Concentrated, stabilized cis-diamminedinitratoplatinum solutions for
11. 4772589 - Etoposide solution in NMP